A review of current phase III clinical trials of plaque psoriasis: under-representation of nonwhite participants and need for reform

被引：11
|
作者：
Reddy, V. D. [1 ]
Myers, B. A. [1 ]
Chan, S. Y. [1 ]
Thibodeaux, Q. G. [1 ]
Brownstone, N. D. [1 ]
Bhutani, T. [1 ]
Liao, W. [1 ]
Lester, J. C. [1 ]
Koo, J. Y. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 02期
关键词：
D O I：
10.1111/bjd.19468
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：348 / 350
页数：3
相关论文
共 25 条
  • [1] Under-representation in Clinical Trials: Participants with rare diseases, reporting and awareness
    McAneney, Helen
    [J]. TRIALS, 2019, 20
  • [2] Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma
    Asher, Samir
    Kazantzi, Aikaterini
    Dekaj, Fatjon
    Steventon, Luke
    Khatun, Aisha
    Ainley, Louise
    McMillan, Annabel
    Rabin, Neil
    Wechalekar, Ashu
    Sive, Jonathan
    Kyriakou, Charalampia
    Papanikolaou, Xenofon
    Xu, Ke
    Mahmood, Shameem
    Wisniowski, Brendan
    Lee, Lydia
    Yong, Kwee
    Popat, Rakesh
    [J]. HAEMATOLOGICA, 2022, 107 (12) : 2961 - 2965
  • [3] Under-representation of racial and ethnic minorities in nail psoriasis randomized clinical trials: A call to action
    Ricardo, Jose W.
    Lipner, Shari R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (06) : E267 - E268
  • [4] Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review
    Parks, Ruth M.
    Holmes, Holly M.
    Cheung, Kwok-Leung
    [J]. ONCOLOGY AND THERAPY, 2021, 9 (01) : 55 - 67
  • [5] Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review
    Ruth M. Parks
    Holly M. Holmes
    Kwok-Leung Cheung
    [J]. Oncology and Therapy, 2021, 9 : 55 - 67
  • [6] Review of therapeutic trends in clinical trials for hidradenitis suppurativa: the rise of biologics and demographic under-representation
    Coleman, Madeline S.
    Mulligan, Kathleen M.
    OConnell, Katie A.
    Ahmad, Areebah
    Kim, Lori
    da Silva, Alexandra
    Newton, Jazmin
    Dellavalle, Robert P.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (02) : 172 - 173
  • [7] Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials
    Howell, Seth T.
    Cardwell, Leah A.
    Feldman, Steven R.
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (04) : 380 - 387
  • [8] Emerging Oral Immunomodulators for the Treatment of Psoriasis: A Review of Phase III Clinical Trials for Apremilast and Tofacitinib
    McAndrew, Rachel
    Levin, Ethan
    Koo, John
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (08) : 786 - 792
  • [9] Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials
    Ramachandran, Vignesh
    Bertus, Brooke
    Bashyam, Arjun M.
    Feldman, Steven R.
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (09) : 872 - 878
  • [10] Safety of extended and long-term efalizumab therapy for plaque psoriasis: Results from phase III clinical trials
    Carey, W
    Menter, A
    Leonardi, C
    Lynde, C
    Ouellet, J
    Toth, D
    Rosoph, L
    Papp, K
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
123